DENNIS WU focuses his practice on international commercial arbitration with an emphasis on disputes with an Asian nexus. He has advised clients in a wide variety of matters (including private equity, M&A, pharmaceutical, construction, and technology) and has acted in ad hoc and institutional proceedings conducted under ICC, HKIAC, SIAC, LCIA, and UNCITRAL arbitration rules. He also has experience in litigation matters, including general commercial litigation, insolvency, and arbitration-related court proceedings.
Dennis graduated with Bachelor of Social Sciences and Bachelor of Laws degrees from the University of Hong Kong. He is fluent in English, Cantonese, and Mandarin Chinese.
This is available in:
- English
- 中文

Senior Managing Associate
Dennis Wu
- Commercial Litigation and Disputes
- Global Arbitration, Trade and Advocacy
Experience
- Representative Matters
His significant experience includes*:
- Representing a Taiwanese conglomerate in a US$1.1 billion HKIAC arbitration against a Japanese trading house. The parties’ dispute arose out of a series of sale and purchase agreements, which required the transfer of (i) certain shares in a Cayman corporation from the Japanese party to our client and (ii) shares in a real estate project from our client to the Japanese party.
- Representing a major pharmaceutical company in an SIAC arbitration concerning disputes arising from the purchase of a portfolio of generic drugs.
- Representing a U.S.-based global investment company in an approximately US$50 million HKIAC arbitration arising from its private equity investment in the P.R.C.
- Representing a P.R.C real estate developer and its related Singapore SPV in an approximately US$100 million HKIAC arbitration concerning a Sino-foreign joint venture dispute with its U.S. private equity fund partner.
- Representing an Asian electronic manufacturing company in a New York-seated ICC arbitration commenced by a U.S.-based purchaser with respect to warranty breaches under various supply and engineering agreements; New York law governs.
- Acting for a Chinese pharmaceutical conglomerate in an approximately US$50 million London-seated LCIA arbitration governed by English law in relation to a pharmaceutical distribution and licensing agreement.
- Advising an electronics and information technology multinational in an approximately US$1 billion ICC arbitration in Tokyo against a U.S. multinational technology company concerning the calculation of patent royalties.
- Representing a global private equity fund in a third-party intervention application before the Hong Kong High Court to amend/discharge an interim injunction in support of an arbitration commenced by a Chinese investor against the founder in respect of ownership over the fund, whose portfolio companies were valued at over US$800 million. The application before the Hong Kong High Court was one of several contentious proceedings between the parties across multiple jurisdictions.
- Advising an engineering conglomerate in an HKIAC arbitration and subsequent mediation at the SIMC in relation to disputes with a subcontractor arising from allocation of responsibility for delays in respect of a pipeline pre-commissioning project in Southeast Asia.
- Advising a Chinese company in connection with allegations of material misstatements and responding to regulatory investigations by the Hong Kong Stock Exchange and the Securities and Futures Commission.
*Includes matters completed prior to joining Sidley.
Capabilities
SERVICES AND INDUSTRIES
News & Insights
Credentials
Admissions & Certifications
- Hong Kong (Solicitor)
Education
- The University of Hong Kong, Postgraduate Certificate in Laws, 2014
- The University of Hong Kong, LL.B., 2013
- The University of Hong Kong, B.S.S., 2011
Languages
- Chinese - Cantonese
- Chinese
- English